69 related articles for article (PubMed ID: 2544115)
1. Well-differentiated cholangiocarcinoma: diagnostic significance of morphologic and immunohistochemical parameters.
Nakajima T; Kondo Y
Am J Surg Pathol; 1989 Jul; 13(7):569-73. PubMed ID: 2544115
[TBL] [Abstract][Full Text] [Related]
2. Well-differentiated peripheral cholangiocarcinoma with an unusual clinical course.
Foucar E; Kaplan LR; Gold JH; Kiang DT; Sibley RK; Bosl G
Gastroenterology; 1979 Aug; 77(2):347-53. PubMed ID: 221305
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
6. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moff SL; Clark DP; Maitra A; Pandey A; Thuluvath PJ
J Clin Gastroenterol; 2006 Apr; 40(4):336-41. PubMed ID: 16633106
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
8. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
10. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component.
Chen TC; Ng KF; Kuo T
Mod Pathol; 2001 May; 14(5):527-32. PubMed ID: 11353065
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
13. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
14. [The expression and significance of proliferating cell nuclear antigen/cyclin in cholangiocarcinoma and gallbladder carcinoma].
Yang Z; Zhong D; Li Y
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):437-8. PubMed ID: 8565737
[TBL] [Abstract][Full Text] [Related]
15. Epithelial membrane antigen expression in cholangiocarcinoma. An useful immunohistochemical tool for differential diagnosis with hepatocarcinoma.
Bonetti F; Chilosi M; Pisa R; Novelli P; Zamboni G; Menestrina F
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):307-13. PubMed ID: 6314640
[TBL] [Abstract][Full Text] [Related]
16. The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma.
Taguchi K; Aishima S; Asayama Y; Kajiyama K; Kinukawa N; Shimada M; Sugimachi K; Tsuneyoshi M
Hepatology; 2001 May; 33(5):1118-23. PubMed ID: 11343239
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of sarcomatous cholangiocarcinoma of the liver.
Shimada M; Takenaka K; Rikimaru T; Hamatsu T; Yamashita Y; Kajiyama K; Taguchi K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2000; 47(34):956-61. PubMed ID: 11020857
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma.
Itatsu K; Fujii T; Sasaki M; Zen Y; Nakanuma Y
Hepatogastroenterology; 2007; 54(75):677-80. PubMed ID: 17591040
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]